comparemela.com
Home
Live Updates
Moderate Disease Severity - Breaking News
Pages:
Latest Breaking News On - Moderate disease severity - Page 2 : comparemela.com
AB Science: Results of masitinib in ALS selected for a scientific platform presentation at the AAN 2023, including long-term survival analysis and a new analysis of patient population with no complete loss of function at baseline
PRESS RELEASE RESULTS OF MASITINIB IN ALS SELECTED FOR A SCIENTIFIC PLATFORM PRESENTATION AT THE AMERICAN ACADEMY OF NEUROLOGY 2023 ANNUAL MEETING, INCLUDING LONG-TERM. | April 12, 2023
United states
France general
Scler frontotemporal degener
Albert ludolph
Olivier hermine
Scientific committee
American academy of neurology
University hospital
Department of neurology
Professor albert ludolph
Medical faculty
American academy
Masitinib shows prolonged survival
Amyotrophic lateral sclerosis
Moderate disease severity
Des sciences
vimarsana © 2020. All Rights Reserved.